Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CopperFixx
- Development stage
- Unknown
- Lead developer
- Quest Products
- Administration
- Topical
01
Overview
**CopperFixx** is a Quest Products topical pain-relief brand. The currently identifiable DailyMed-listed formulation is an unapproved homeopathic ointment containing Cuprum metallicum 11X HPUS and Arnica montana 4X HPUS, labeled for temporary relief of minor muscle and joint aches associated with arthritis, simple backache, strains, and bruises. It is applied topically. The product label states that it has not been evaluated by the FDA for safety or efficacy and that the FDA is not aware of scientific evidence supporting homeopathy as effective. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=ff2d3197-a8f3-46ff-899d-670a953d41d5))
- Brand names
- CopperFixx
Beyond the preview
Go deeper on CopperFixx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CopperFixx.